4 completed, 1 unknown, 1 withdrawn. 2 Not applicable, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow HIV-associated Hodgkin Lymphoma: new trials by email Literature Review of HIV-associated Hodgkin Lymphoma trials Research Report on HIV-associated Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma carmustine, cytarabine, melphalan - Adult Nasal Type Extranodal NK/T-cell Lymphoma, AIDS-related Diffuse Large Cell Lymphoma | Not applicable | Withdrawn | Fred Hutchinson Cancer Center | 2015-02-01 | 2015-05-07 | |
| RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors gamma-secretase/Notch signalling pathway inhibitor RO4929097, capecitabine, laboratory biomarker analysis - Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2010-06-01 | 2014-11-07 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy sunitinib malate, pharmacological study, laboratory biomarker analysis - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Phase 1 | Completed | National Cancer Institute (NCI) | 42 | 2009-08-01 | 2014-03-17 |
| Prospective Study on HIV-related Hodgkin Lymphoma Doxorubicin, Bleomycin, Vinblastine - HIV-associated Hodgkin Lymphoma | Phase 2 | Unknown | Harlachinger Krebshilfe e.V. | 130 | 2004-03-01 | 2011-11-09 |
| Topotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatment topotecan hydrochloride, laboratory biomarker analysis - AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma | Phase 2 | Completed | National Cancer Institute (NCI) | 77 | 2000-04-01 | 2013-02-21 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer fludarabine phosphate, total-body irradiation, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia | Not applicable | Completed | Fred Hutchinson Cancer Center | 5 | 1999-11-01 | 2017-05-24 |
Burkitt Lymphoma (5) · Lymphoma, Large B-Cell, Diffuse (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (5) · Hodgkin Disease (4) · Immunoblastic Lymphadenopathy (4) · Intraocular Lymphoma (4) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Lymphoma, B-Cell, Marginal Zone (4) · Lymphoma, Extranodal NK-T-Cell (4) · Lymphoma, Follicular (4) · Lymphoma, Large-Cell, Anaplastic (4) · Lymphoma, Large-Cell, Immunoblastic (4) · Lymphoma, Mantle-Cell (4) · Lymphoma, Non-Hodgkin (4) · Lymphoma, T-Cell, Cutaneous (4)
DNA Virus Infections (5) · Disease Attributes (5) · Epstein-Barr Virus Infections (5) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Herpesviridae Infections (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Infections (5) · Leukemia, Lymphoid (5) · Lymphatic Diseases (5) · Lymphoma, B-Cell (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5)
Etoposide (2) · Peripheral Blood Stem Cell Transplantation (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · Bleomycin (1) · Capecitabine (1) · Carmustine (1) · Cyclophosphamide (1) · Cyclosporine (1) · Cytarabine (1) · Dacarbazine (1) · Doxorubicin (1) · Melphalan (1) · Mycophenolic Acid (1) · O(6)-benzylguanine (1) · Prednisone (1)
National Cancer Institute (NCI) (3) · Fred Hutchinson Cancer Center (2) · Harlachinger Krebshilfe e.V. (1)
United States (5) · Canada (1) · Germany (1)
Ann Woolfrey (2) · John Deeken (1) · Marcus Hentrich, MD (1) · Noelle LoConte (1) · Susan Blaney (1)
PMID 18698002, PMID 22259028, PMID 24474568
P30CA015704 (2), P01CA018029 (1), P30CA014520 (1), U01CA062491 (1), U01CA121947 (1), U01CA132123 (1), U10CA098543 (1)